CREPT may promote the proliferation of lymphoma cells and inhibit their differentiation by combining with related transcription factors, thereby promoting the occurrence of T-cell lymphoma. The gene discussed is RPRD1B; the disease is T-cell non-Hodgkin lymphoma.